Stock listing
NASDAQ:PEPG PepGen Inc. Stock
Home listing (NASDAQ) of PepGen Inc.
Follow PepGen Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:PEPG
$2.36 USD -0.05 (-2.1%)
Close on Oct 30, 2026
- Day range
- $2.22 – $2.41 USDOct 30, 2026
- Volume
- 1.13M sharesOct 30, 2026
- Market cap
- $163.2M USDAt the close on Oct 30, 2026 · price × 69.17M shares outstanding
- 52-week range
- $1.31 – $7.80 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $2.53M USDMedian day 729,200 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:PEPG · Home | $2.36 USD | -0.05 (-2.1%) | 1,127,762 | $2.40 | $2.405 | $2.22 | $2.41 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:PEPG · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $2.36 | -0.05 | -2.1% | $2.40 | $2.405 | $2.22 | 1,127,762 | |
| $2.41 | -0.12 | -4.7% | $2.54 | $2.61 | $2.402 | 766,432 | |
| $2.53 | -0.07 | -2.7% | $2.58 | $2.64 | $2.485 | 767,793 | |
| $2.60 | +0.11 | +4.4% | $2.49 | $2.62 | $2.47 | 1,331,516 | |
| $2.49 | -0.03 | -1.2% | $2.51 | $2.675 | $2.46 | 906,708 | |
| $2.52 | -0.18 | -6.7% | $2.68 | $2.80 | $2.44 | 1,161,300 | |
| $2.70 | -0.02 | -0.7% | $2.71 | $2.83 | $2.65 | 1,041,900 | |
| $2.72 | -0.15 | -5.2% | $2.89 | $2.99 | $2.72 | 1,173,900 | |
| $2.87 | +0.17 | +6.3% | $2.66 | $2.94 | $2.62 | 2,761,600 | |
| $2.70 | +0.10 | +3.8% | $2.55 | $2.73 | $2.495 | 1,083,000 | |
| $2.60 | +0.07 | +2.8% | $2.56 | $2.69 | $2.50 | 1,199,500 | |
| $2.53 | +0.21 | +9.1% | $2.30 | $2.60 | $2.30 | 764,200 | |
| $2.32 | -0.18 | -7.2% | $2.44 | $2.49 | $2.26 | 917,300 | |
| $2.50 | +0.01 | +0.4% | $2.48 | $2.60 | $2.41 | 1,218,300 | |
| $2.49 | -0.13 | -5.0% | $2.61 | $2.61 | $2.48 | 315,800 | |
| $2.62 | +0.24 | +10.1% | $2.39 | $2.65 | $2.39 | 603,700 | |
| $2.38 | -0.02 | -0.8% | $2.38 | $2.447 | $2.28 | 844,600 | |
| $2.40 | +0.09 | +3.9% | $2.31 | $2.48 | $2.275 | 642,800 | |
| $2.31 | -0.05 | -2.1% | $2.38 | $2.385 | $2.26 | 590,200 | |
| $2.36 | +0.08 | +3.5% | $2.30 | $2.39 | $2.255 | 606,400 | |
| $2.28 | +0.07 | +3.2% | $2.24 | $2.31 | $2.225 | 744,400 | |
| $2.21 | -0.21 | -8.7% | $2.38 | $2.425 | $2.21 | 782,900 | |
| $2.42 | +0.08 | +3.4% | $2.34 | $2.525 | $2.34 | 2,149,500 | |
| $2.34 | -0.25 | -9.7% | $2.61 | $2.65 | $2.32 | 2,349,500 | |
| $2.59 | 0.00 | 0.0% | $2.55 | $2.645 | $2.46 | 740,000 | |
| $2.59 | -0.09 | -3.4% | $2.68 | $2.72 | $2.585 | 513,200 | |
| $2.68 | -0.04 | -1.5% | $2.71 | $2.715 | $2.63 | 657,400 | |
| $2.72 | -0.26 | -8.7% | $2.95 | $2.96 | $2.695 | 715,400 | |
| $2.98 | +0.14 | +4.9% | $2.84 | $3.03 | $2.82 | 523,500 | |
| $2.84 | -0.01 | -0.4% | $2.88 | $2.915 | $2.80 | 652,400 | |
| $2.85 | -0.12 | -4.0% | $2.97 | $2.98 | $2.835 | 580,400 | |
| $2.97 | +0.07 | +2.4% | $2.90 | $2.99 | $2.85 | 447,600 | |
| $2.90 | +0.01 | +0.3% | $2.92 | $2.975 | $2.85 | 613,200 | |
| $2.89 | -0.08 | -2.7% | $2.93 | $2.94 | $2.84 | 567,300 | |
| $2.97 | -0.01 | -0.3% | $2.99 | $3.10 | $2.91 | 718,400 | |
| $2.98 | -0.04 | -1.3% | $3.03 | $3.10 | $2.95 | 683,000 | |
| $3.02 | -0.13 | -4.1% | $3.13 | $3.13 | $3.00 | 972,800 | |
| $3.15 | -0.06 | -1.9% | $3.17 | $3.48 | $3.10 | 1,153,700 | |
| $3.21 | +0.10 | +3.2% | $3.06 | $3.24 | $2.91 | 1,929,700 | |
| $3.11 | -0.07 | -2.2% | $3.14 | $3.195 | $3.10 | 201,000 | |
| $3.18 | 0.00 | 0.0% | $3.18 | $3.25 | $3.10 | 514,300 | |
| $3.18 | +0.06 | +1.9% | $3.15 | $3.30 | $3.085 | 352,700 | |
| $3.12 | +0.13 | +4.3% | $2.95 | $3.165 | $2.91 | 461,800 | |
| $2.99 | -0.09 | -2.9% | $3.04 | $3.05 | $2.92 | 365,800 | |
| $3.08 | +0.01 | +0.3% | $3.05 | $3.13 | $2.98 | 484,900 | |
| $3.07 | -0.15 | -4.7% | $3.22 | $3.30 | $3.07 | 469,900 | |
| $3.22 | -0.205 | -6.0% | $3.41 | $3.41 | $3.11 | 952,000 | |
| $3.425 | +0.235 | +7.4% | $3.21 | $3.57 | $3.19 | 985,000 | |
| $3.19 | +0.05 | +1.6% | $3.14 | $3.23 | $3.04 | 482,700 | |
| $3.14 | +0.105 | +3.5% | $3.09 | $3.23 | $3.031 | 671,800 | |
| $3.035 | -0.015 | -0.5% | $3.04 | $3.18 | $3.03 | 969,500 | |
| $3.05 | +0.14 | +4.8% | $2.98 | $3.08 | $2.875 | 780,100 | |
| $2.91 | -0.13 | -4.3% | $3.03 | $3.085 | $2.895 | 677,200 | |
| $3.04 | +0.05 | +1.7% | $3.00 | $3.08 | $2.93 | 670,900 | |
| $2.99 | +0.01 | +0.3% | $2.95 | $3.00 | $2.85 | 615,500 | |
| $2.98 | +0.08 | +2.8% | $2.90 | $3.05 | $2.80 | 1,394,600 | |
| $2.90 | 0.00 | 0.0% | $2.86 | $2.98 | $2.86 | 768,000 | |
| $2.90 | -0.09 | -3.0% | $3.04 | $3.14 | $2.86 | 1,145,200 | |
| $2.99 | +0.14 | +4.9% | $2.90 | $3.04 | $2.75 | 1,525,200 | |
| $2.85 | +0.44 | +18.3% | $2.48 | $2.875 | $2.44 | 3,224,000 | |
| $2.41 | +0.43 | +21.7% | $2.10 | $2.46 | $2.06 | 4,475,900 | |
| $1.98 | +0.05 | +2.6% | $1.96 | $1.99 | $1.87 | 668,200 | |
| $1.93 | +0.05 | +2.7% | $1.88 | $1.95 | $1.84 | 357,200 | |
| $1.88 | +0.12 | +6.8% | $1.77 | $1.93 | $1.77 | 347,600 | |
| $1.76 | -0.02 | -1.1% | $1.83 | $1.88 | $1.71 | 296,800 | |
| $1.78 | +0.07 | +4.1% | $1.72 | $1.78 | $1.68 | 466,900 |
- Ticker
- NASDAQ:PEPG
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Aug 6, 2026
PepGen Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
Latest deck · Aug 6, 2026
Investor Presentation (August 2026)
Investor deck · 29 slides
Calls
Replays
Pepgen (NASDAQ:PEPG) Q4 2023 Earnings Call
Thu, Mar 06, 2025 · 4:30 PM ET
Watch Transcript
Latest news
PepGen Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
Aug 6, 2026
Closed $2.41 (+21.7%) on Aug 6, 2026
PepGen to Advance PGN-EDODM1 Into Highest Dose Cohort in Phase 2 FREEDOM2-DM1 Study Following DSMB Review
Aug 6, 2026
Closed $2.41 (+21.7%) on Aug 6, 2026
PepGen Announces Presentations at the 15th International Myotonic Dystrophy Consortium Highlighting Clinical Data from the PGN-EDODM1 Program
May 21, 2026
Closed $1.54 (+6.9%) on May 21, 2026
PepGen Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
May 12, 2026
Closed $1.78 (+6.0%) on May 13, 2026
PepGen Announces Topline Results from Lowest Dose (5 mg/kg) MAD Cohort in the Ongoing Phase 2 FREEDOM2 Study Demonstrating Favorable Safety, Splicing and vHOT Data
Mar 30, 2026
Closed $4.23 (-6.4%) on Mar 30, 2026
PepGen Reports Fourth Quarter and Year-End 2025 Financial Results and Recent Corporate Highlights
Mar 4, 2026
Closed $6.76 (+5.3%) on Mar 4, 2026
PepGen Announces Regulatory Updates on FREEDOM2
Mar 4, 2026
Closed $6.76 (+5.3%) on Mar 4, 2026
PepGen to Participate in the Leerink Global Healthcare Conference
Mar 3, 2026
Closed $6.42 (-1.7%) on Mar 3, 2026
PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Business and Legal Officer
Dec 9, 2025
Closed $5.70 (+2.0%) on Dec 9, 2025
PepGen Appoints Joseph Vittiglio, Esq., as Chief Business and Legal Officer
Dec 8, 2025
Closed $5.59 (+2.8%) on Dec 8, 2025
Decks
Investor Presentation (August 2026)
Investor deck · 29 slides · Aug 6, 2026
Investor Presentation (August 2026)
Investor deck · 29 slides · August 2026
Investor Presentation (May 2026)
Investor deck · 27 slides · May 21, 2026
IDMC 2026 Late-Breaker
Conference · 19 slides · May 2026
PepGen Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 13 in the last 12 months · 82 in all · newest Aug 6, 2026 · oldest 2022
- Decks
- 17 decks · latest Aug 6, 2026
Where PepGen Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:PEPG · Home listing · This page | NASDAQ | United States | USD |
| BOATS:PEPG | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about PepGen Inc.